Michael Jelinek to Radiosurgery
This is a "connection" page, showing publications Michael Jelinek has written about Radiosurgery.
Connection Strength
0.192
-
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. J Thorac Oncol. 2022 01; 17(1):130-140.
Score: 0.192